A: REGULATOR OF RIBONUCLEASE ACTIVITY A B: REGULATOR OF RIBONUCLEASE ACTIVITY A C: REGULATOR OF RIBONUCLEASE ACTIVITY A D: REGULATOR OF RIBONUCLEASE ACTIVITY A E: REGULATOR OF RIBONUCLEASE ACTIVITY A F: REGULATOR OF RIBONUCLEASE ACTIVITY A G: REGULATOR OF RIBONUCLEASE ACTIVITY A H: REGULATOR OF RIBONUCLEASE ACTIVITY A I: REGULATOR OF RIBONUCLEASE ACTIVITY A J: REGULATOR OF RIBONUCLEASE ACTIVITY A K: REGULATOR OF RIBONUCLEASE ACTIVITY A L: REGULATOR OF RIBONUCLEASE ACTIVITY A M: ATP-DEPENDENT RNA HELICASE RHLB N: ATP-DEPENDENT RNA HELICASE RHLB
Mass: 18.015 Da / Num. of mol.: 65 / Source method: isolated from a natural source / Formula: H2O
Sequence details
CHAINS M AND N ARE PEPTIDE OF SEQUENCE YRLTRPRTGNGPRRTGAPRNRRRSG WHICH CORRESPONDS TO RESIDUES 398- ...CHAINS M AND N ARE PEPTIDE OF SEQUENCE YRLTRPRTGNGPRRTGAPRNRRRSG WHICH CORRESPONDS TO RESIDUES 398-421 OF RHLB (UNIPROT P0A8J8) WITH AN ADDED N-TERMINAL TYROSINE RESIDUE, TO ENABLE ESTIMATION OF PEPTIDE CONCENTRATION BY UV ABSORPTION
-
Experimental details
-
Experiment
Experiment
Method: X-RAY DIFFRACTION / Number of used crystals: 1
-
Sample preparation
Crystal
Density Matthews: 2.58 Å3/Da / Density % sol: 52 % / Description: NONE
Crystal grow
Temperature: 298 K / Method: vapor diffusion, hanging drop / pH: 5.4 Details: CRYSTALS WERE OBTAINED USING THE HANGING DROP METHOD, BY MIXING IN 1 TO 1 RATIO PROTEIN SAMPLE WITH MOTHER LIQUOR 100 MM SODIUM CITRATE PH 5.4, 32% MPD AND 200 MM AMMONIUM ACETATE AT 25 C. ...Details: CRYSTALS WERE OBTAINED USING THE HANGING DROP METHOD, BY MIXING IN 1 TO 1 RATIO PROTEIN SAMPLE WITH MOTHER LIQUOR 100 MM SODIUM CITRATE PH 5.4, 32% MPD AND 200 MM AMMONIUM ACETATE AT 25 C. PLATES WERE THEN IMMEDIATELY TRANSFERRED TO 16 C. CRYSTALS WERE DIRECTLY FLASH FROZEN IN LIQUID NITROGEN.
Resolution: 2.8→122.62 Å / Cor.coef. Fo:Fc: 0.935 / Cor.coef. Fo:Fc free: 0.888 / SU B: 19.997 / SU ML: 0.384 / Cross valid method: THROUGHOUT / ESU R Free: 0.456 / Stereochemistry target values: MAXIMUM LIKELIHOOD / Details: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS.